Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

PubMed
Indexed incrossrefpubmed

Abstract

Abstract Background On the basis of recent clinical trial data for the treatment of drug-susceptible and drug-resistant tuberculosis (TB), the American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America have updated clinical practice guidelines for TB treatment in children and adults in settings in which mycobacterial cultures, molecular and phenotypic drug susceptibility tests, and radiographic studies, among other diagnostic tools, are available on a routine basis. Methods A Joint Panel representing multiple interdisciplinary perspectives convened with American Thoracic Society methodologists to review evidence and make…

Citation impact

112
total citations
FWCI
39.66
Percentile
100%
References
30
Citations per year

Authors

28

Topics & keywords

Keywords
  • Medicine
  • Guideline
  • Drug
  • Tuberculosis
  • Clinical Practice
  • Drug resistance
  • Intensive care medicine
  • Family medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding